Long-Acting Injectable Antipsychotics Cut Readmission for Schizophrenia

Reduction in 30-day readmission rate seen for schizophrenia or schizoaffective disorder with long-acting versus oral antipsychotics.

Related Keywords

New Jersey ,United States ,Pragya Thaman ,Daniel Greer ,Rutgers University Ernest Mario School Of Pharmacy ,Rutgers Pharmaceutical Fellowship Program In Piscataway ,Healthday News ,Rutgers Pharmaceutical Fellowship Program ,Rutgers University Ernest Mario School ,